On September 18, 2020, the Center for Medicare and Medicaid Innovation Center issued a final rule establishing a Radiation Oncology Alternative Payment Model (RO Model), effective January 1, 2021. ASTRO has grave concerns about the success of the RO Model given that CMS accepted very few recommendations that ASTRO provided in response to the July 2019 proposed rule. We are particularly disappointed in the Agency’s decision to rapidly implement a mandatory model, which has never been tested, on January 1, 2021. Additionally, ASTRO is very disappointed that the Agency only made minimal modifications to the payment methodology to address our concerns regarding the Model’s financial impact, which could result in financial jeopardy rather than stability for some practices. These concerns are heightened by the financial impact that COVID-19 has had and will likely continue to have on the finances of radiation oncology practices nationwide.
This page is designed to provide radiation oncology practices with resources for implementing the final rule, ASTRO’s advocacy efforts to address the Model’s flaws and background that details the model’s development over the last several years.
Summary (long version)
Summary (short version)
Payment Methodology Webinar
Process and Procedures Webinar
National Base Rates List
Become an Advocate
RO Model Concerns Letter
Verma Follow Up Letter
Sign On Letter
2019 Radiation Oncology APM: Why Us? Why Now?
2019 RO Model Proposed Rule
2019 ASTRO Comment Letter in Response to the Proposed Rule
2017 CMMI report on the viability of an RO Model